Putative precursors of uterine sarcomas

Qing Zhang, Jian Jun Wei*

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter


Objective: Uterine sarcomas are rare tumors that account for 3–7 % of uterine cancers. Currently, the definition and diagnosis of uterine sarcomas are largely based on the newly revised classification by the World Health Organization (WHO, 2014). The pathogenesis of uterine sarcoma remains largely unknown. This review summarizes the available clinical, pathological, and especially molecular findings for uterine sarcomas. Methods: Medline was searched for publications in English between 1980 and 2014. The publications which represent either a larger number of case series or typical morphologic and molecular studies for uterine sarcomas were reviewed and cited in this chapter. Conclusions: Each uterine sarcoma type has its own characteristic clinicopathological, prognostic, and specific molecular genetic alterations. Updated information and new insights into the molecular biology for tumorigenesis of uterine sarcoma are described and discussed.

Original languageEnglish (US)
Title of host publicationPrecancerous Lesions of the Gynecologic Tract
Subtitle of host publicationDiagnostic and Molecular Genetic Pathology
PublisherSpringer International Publishing
Number of pages22
ISBN (Electronic)9783319225098
ISBN (Print)9783319225081
StatePublished - Jan 1 2015


  • Adenosarcoma
  • Endometrial stromal sarcoma
  • Leiomyosarcoma
  • Molecular aberration
  • Tumor origin
  • Undifferentiated endometrial sarcoma
  • Uterine carcinosarcoma

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Putative precursors of uterine sarcomas'. Together they form a unique fingerprint.

Cite this